MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Motor, epileptic, and developmental phenotypes in genetic disorders affecting G-protein coupled receptor signaling and cAMP metabolism

    S. Galosi, L. Pollini, M. Novelli, K. Bernardi, M. Di Rocco, S. Martinelli, V. Leuzzi (Rome, Italy)

    Objective: To provide a detailed clinical characterization of genetic disorders affecting G-protein coupled receptor signaling and cAMP metabolism Background: Genetic disorders affecting G-protein coupled receptor (GPCRs) signaling…
  • 2022 International Congress

    DBS for a patient with KMT2B-SHANK2 related dystonia

    L. Pan, G. Riboldi, A. Mogilner, C. Toro, S. Frucht (New York, USA)

    Objective: Describe a case of deep brain stimulation (DBS) outcome for a patient with pathogenic variants of Shank2 and KMT2B genes. Background: Prior reports have…
  • 2022 International Congress

    Improvement of masticatory muscles’ pain versus tenderness via electromyography biofeedback training in patients with bruxism.

    M. Amine, U. El-Dakrory (Mohandessine, Egypt)

    Objective: To determine if masticatory muscles’ pain and tenderness in bruxers should be treated independently. Background: Bruxism is a movement disorder with marked hyperactivity in the…
  • 2022 International Congress

    Association between thyroid dysfunction and severity of depression in de novo patients with Parkinson’s disease

    I. Sarac, H. Sarac, N. Henigsberg, F. Borovecki, L. Bagaric Krakan, I. Ivek, M. Iveta, T. Sukobljevic, Z. Kresic (Zagreb, Croatia)

    Objective: This study aimed to evaluate the association between thyroid disturbances and severity of depression in de novo PD patients Croatian residents. Background: Thyroid disease…
  • 2022 International Congress

    Knowledge and attitude of Egyptian general public towards Parkinson disease: A cross-sectional study in Egypt.

    M. Alwerdani, A. Hassanin, A. Ashour, A. Khalil, R. Elbayar, M. Doheim, N. Elsaid, A. Shalash (Cairo, Egypt)

    Objective: We aim to investigate the public Egyptian knowledge and attitude towards PD. Background: In Egypt, the PD prevalence reached 316.50 per 100,000 people. Given…
  • 2022 International Congress

    Endocannabinoid Dysfunction in Human Disease: Neuro-Ocular DAGLA-related Syndrome (NODrS), a unique pediatric condition

    J. Friedman, A. Mazumder, D. Ogasawara, R. Abou Jamra, G. Bernard, E. Bertini, L. Burglen, A. Crawford, H. Cope, A. Derksen, L. Dure, E. Gantz, M. Koch-Hogrebe, A. Hurst, S. Mahida, P. Marshall, A. Micalizzi, A. Novelli, H. Peng, *. Rady-Children'S-Institute-For-Genomic-Medicine, D. Rodriguez, S. Robbins, L. Rutledge, R. Scalise, S. Schließke, V. Shashi, S. Srivastava, I. Thiffault, S. Topol, *. Undiagnosed-Disease-Network, L. Qebibo, D. Wieczorek, B. Cravatt, S. Haricharan, A. Torkamani, M. Bainbridge (San Diego, USA)

    Objective: To define a new pediatric movement disorder and conclusively link the endocannabinoid system to human disease. Background: The endocannabinoid system is a highly conserved…
  • 2022 International Congress

    PLA2G6-related dystonia-parkinsonism in identical twins manifesting at an advanced age: a case report and review of the literature.

    D. Sugar, K. Kompoliti (Chicago, USA)

    Objective: To report a rare presentation of a rare disease and illustrate the range of phenotype seen in PLA2G6-associated dystonia-parkinsonism (PLADP). Background: PLA2G6 encodes a…
  • 2022 International Congress

    Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study of Ecopipam in Children and Adolescents with Tourette Syndrome

    A. Mahableshwarkar, J. Dubow, T. Cunniff, S. Wanaski (Chicago, USA)

    Objective: Evaluate the efficacy and safety of ecopipam in children and adolescents with Tourette’s Syndrome (TS). Background: Ecopipam, a first-in-class selective dopamine-1 (D1) receptor antagonist…
  • 2022 International Congress

    Current Concepts in Physical Therapy and Rehabilitation Protocol for Camptocormia: An Unusual Case Report

    S. Calisgan, E. Calisgan, M. Ceylan, Y-E. Aktas (Manchester, United Kingdom)

    Objective: To investigate symptoms observed in patients with Parkinson’s Disease with camptocormia and prepare a protocol for physical therapy in addition to medical and surgical…
  • 2022 International Congress

    Within patient comparison of neurostimulator longevity; sequentially contrasting the Medtronic Activa PC to the Medtronic Percept PC utilizing in-device battery estimates

    E. Hargreaves, D. Caputo, D. Dolce, R. Dipaola, S. Danish (Neptune, USA)

    Objective: To examine the differences between Actual Activa PC longevity and the estimated longevity of the Percept PC, utilizing identical contact configurations and programming parameters.…
  • « Previous Page
  • 1
  • …
  • 604
  • 605
  • 606
  • 607
  • 608
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley